Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.
Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.
High Tide Inc. (NASDAQ: HITI) has secured a $30 million convertible debt through a loan agreement with Cronos Group Inc. The junior secured loan bears a 4% annual interest rate and has a 5-year term. The debt is convertible into High Tide common shares at $4.20 per share.
As part of the deal, Cronos received a warrant exercisable into 3,836,317 common shares at $3.91 per share, representing a 25% premium to the 30-day VWAP. High Tide plans to use the capital for future acquisitions and organic growth, aiming to expand its Canadian store network beyond 300 locations. The company currently operates 202 Canna Cabana locations across Canada, making it the second-largest cannabis retailer globally by store count.
Cronos Group (NASDAQ: CRON) has announced its expansion into the Swiss medical cannabis market through a partnership with Dascoli Pharma AG. Under the agreement, Cronos will supply its PEACE NATURALS® branded cannabis flower products through Dascoli's established medical network in Switzerland.
The expansion includes five cannabis flower varieties: GMO Cookies, Space Cake, Atomic Sour Grapefruit, Sonic Lemon Fuel, and Wedding Cake. The PEACE NATURALS® brand is now available in seven international markets, including Australia, Canada, Germany, Israel, Malta, Switzerland, and the UK.
Cronos Group (NASDAQ: CRON) announced the results of its 2025 Annual Meeting of Shareholders, with a 71.87% shareholder participation representing 276,989,452 common shares. All nominated directors were successfully elected with over 92.3% approval rates. Notably, shareholders approved the executive compensation advisory resolution with 94.13% support and confirmed Davidson & Company LLP as the independent auditor for fiscal year 2025.
The board election saw strong support for all directors, with Dominik Meier receiving the highest approval at 96.94%, followed by Kamran Khan at 96.92%. Michael Gorenstein received 92.38% of votes in favor, representing the lowest but still overwhelmingly positive support among the directors.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has announced its upcoming 2025 Annual Meeting of Shareholders, scheduled for Friday, June 20, 2025, at 11:00 a.m. ET. The meeting will be conducted in a virtual-only format through a live audio webcast.
Key Meeting Details:
- Shareholders and proxyholders can participate remotely regardless of location
- Participants will have opportunities to ask questions and vote
- Meeting access available at virtualshareholdermeeting.com/CRON2025
- Detailed instructions and formal business agenda available on Cronos investor relations website
A replay of the Annual Meeting will be accessible through the company's investor relations website approximately 24 hours after the event concludes. The virtual format ensures equal participation opportunities for all registered shareholders and appointed proxyholders.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has scheduled its 2025 first quarter earnings conference call for Thursday, May 8, 2025, at 8:30 a.m. ET. The company's senior management will present financial results and take questions from the investment community following prepared remarks.
Interested participants can register for the conference call and webcast through the company's investor relations website at https://ir.thecronosgroup.com/events-presentations. To ensure timely access, participants are encouraged to dial in fifteen minutes before the scheduled start time. A replay of the webcast will be made available on Cronos' website after the event.
Cronos Group (NASDAQ: CRON) has announced the launch of new cannabis products under its Spinach® brand, introducing three new 1.2g vape products and expanding its SOURZ by Spinach® edible line.
The new vape lineup features:
- Mango Kiwi Haze CBC (Sativa) with 1:10 CBC-to-THC ratio
- Peach Passionfruit Kush CBN (Indica) with 1:10 CBN-to-THC ratio
- Strawberry Watermelon OG CBG (Hybrid) with 1:10 CBG-to-THC ratio
Each vape contains 1,000mg of THC and features winterized, distilled cannabis extract with ceramic heaters and stainless steel components. The SOURZ by Spinach® Fully Blasted lineup includes new 10mg THC gummies enhanced with rare cannabinoids in three flavors: Mango Lime (with CBC), Peach Passionfruit (with CBN), and Strawberry Watermelon (with CBG).
Cronos Group (NASDAQ: CRON) has appointed Anna Shlimak as Chief Financial Officer, effective March 19, 2025. Shlimak, previously serving as Chief Strategy Officer, succeeds James Holm who will remain with the company through April 18, 2025 to ensure a smooth transition.
Shlimak has been a key member of Cronos' leadership team for seven years, where she has led strategic initiatives in cost optimization, revenue growth, and corporate brand building. CEO Mike Gorenstein expressed confidence in Shlimak's ability to drive financial strategy and growth, citing her deep understanding of the business and track record in driving financial performance.
James Holm, departing after two and a half years, will pursue other opportunities after contributing to improving the company's finance functions and building a robust finance team.
Cronos Group (NASDAQ: CRON) (TSX: CRON), a global cannabinoid company, has announced its participation in the upcoming 37th Annual Roth Conference. Mike Gorenstein, who serves as Chairman, President and CEO, will deliver a presentation on Monday, March 17, 2025, at 1:00 PM PT.
Investors and interested parties can access a live webcast of the presentation through the Investors section of Cronos Group's website at ir.thecronosgroup.com/events-presentations.